81
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparative Analysis of Volatile Terpenoids Composition in Lavender Leaves in Response to Gamma Irradiation and Anticancer Effect of α-Santalene against Prostate Cancer

, , , , &
Pages 244-252 | Received 17 Aug 2022, Accepted 19 Apr 2023, Published online: 11 Jun 2023
 

Abstract

Many studies have been reported on the pharmacological effects and extraction methods of lavender essential oil, but little is known about a profiling analysis of terpenoids produced in lavender leaves by ionizing irradiation. Here, we performed the profiling analysis of volatile terpenoids produced by lavender (Lavandula angustifolia L.) leaves in response to gamma irradiation and the anticancer effects of terpenes induced by γ-irradiation. The analyses of volatile terpenoids revealed that lavender leaves biosynthesised 33 species of volatile terpenoids and their relative ratio were significantly changed after exposure to γ-ray. The relative ratio of monoterpene hydrocarbons such as limonene, p-cymene, and camphene (except for δ-3-carene, γ-terpinene, terpinolene, and allo-ocimene) was reduced to less than 60% at 1000 Gy, set to 100% at 0 Gy. On the contrary, the ratio of sesquiterpene hydrocarbons such as α-santalene, (E)-α-bergamotene, and γ-cadinene was up-regulated by more than 1.6-fold at 1000 Gy. Additionally, α-santalene, which was increased the most by γ-irradiation, significantly inhibited the proliferation of the human prostate cancer cell line (PC3) with an IC50 < 12.5 μg mL-1. Our findings indicate that the α-santalene is the most induced terpenoid after exposure to γ-ray in lavender leaves and that it has a pharmacological effect on reducing the cell viability in human prostate cancer cells. We suggest that non-destructive reconstitution of secondary metabolites in target plants (e.g., medicinal plants) can be achieved by using γ-irradiation as a tool.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.